Barclays’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $61K | Buy |
+1,491
| New | +$61K | ﹤0.01% | 3923 |
|
|
2024
Q2 | – | Sell |
-100
| Closed | -$4K | – | 4343 |
|
|
2024
Q1 | $4K | Hold |
100
| – | – | ﹤0.01% | 4079 |
|
|
2023
Q4 | $4K | Sell |
100
-100
| -50% | -$4K | ﹤0.01% | 4105 |
|
|
2023
Q3 | $8K | Buy |
200
+100
| +100% | +$4K | ﹤0.01% | 4067 |
|
|
2023
Q2 | $4K | Hold |
100
| – | – | ﹤0.01% | 4129 |
|
|
2023
Q1 | $4K | Hold |
100
| – | – | ﹤0.01% | 4187 |
|
|
2022
Q4 | $4K | Hold |
100
| – | – | ﹤0.01% | 4236 |
|
|
2022
Q3 | $4K | Hold |
100
| – | – | ﹤0.01% | 4418 |
|
|
2022
Q2 | $4K | Hold |
100
| – | – | ﹤0.01% | 4513 |
|
|
2022
Q1 | $5K | Hold |
100
| – | – | ﹤0.01% | 4585 |
|
|
2021
Q4 | $5K | Sell |
100
-110
| -52% | -$5.5K | ﹤0.01% | 3170 |
|
|
2021
Q3 | $10K | Sell |
210
-734
| -78% | -$35K | ﹤0.01% | 3755 |
|
|
2021
Q2 | $49K | Buy |
944
+844
| +844% | +$43.8K | ﹤0.01% | 3401 |
|
|
2021
Q1 | $5K | Hold |
100
| – | – | ﹤0.01% | 3761 |
|
|
2020
Q4 | $5K | Hold |
100
| – | – | ﹤0.01% | 3466 |
|
|
2020
Q3 | $4K | Hold |
100
| – | – | ﹤0.01% | 3640 |
|
|
2020
Q2 | $4K | Hold |
100
| – | – | ﹤0.01% | 3702 |
|
|
2020
Q1 | $4K | Sell |
100
-47,300
| -100% | -$1.89M | ﹤0.01% | 3565 |
|
|
2019
Q4 | $2.17M | Hold |
47,400
| – | – | ﹤0.01% | 1824 |
|
|
2019
Q3 | $1.69M | Hold |
47,400
| – | – | ﹤0.01% | 1896 |
|
|
2019
Q2 | $1.89M | Sell |
47,400
-150,000
| -76% | -$5.97M | ﹤0.01% | 1857 |
|
|
2019
Q1 | $8.21M | Buy |
197,400
+150,000
| +316% | +$6.24M | 0.01% | 816 |
|
|
2018
Q4 | $1.74M | Buy |
+47,400
| New | +$1.74M | ﹤0.01% | 1440 |
|
|
2017
Q2 | – | Sell |
-560
| Closed | -$23K | – | 4103 |
|
|
2017
Q1 | $23K | Sell |
560
-200,000
| -100% | -$8.21M | ﹤0.01% | 3335 |
|
|
2016
Q4 | $7.84M | Hold |
200,560
| – | – | 0.01% | 588 |
|
|
2016
Q3 | $8.86M | Hold |
200,560
| – | – | 0.01% | 496 |
|
|
2016
Q2 | $8.38M | Sell |
200,560
-449,440
| -69% | -$18.8M | 0.01% | 536 |
|
|
2016
Q1 | $26M | Buy |
+650,000
| New | +$26M | 0.04% | 237 |
|